Advertisement
Singapore markets closed

  • Straits Times Index

    3,189.59
    +34.90 (+1.11%)
     

  • S&P 500

    5,022.21
    -29.20 (-0.58%)
     

  • Dow

    37,753.31
    -45.66 (-0.12%)
     

  • Nasdaq

    15,683.37
    -181.88 (-1.15%)
     

  • Bitcoin USD

    61,361.85
    -2,022.52 (-3.19%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • FTSE 100

    7,884.20
    +36.21 (+0.46%)
     

  • Gold

    2,394.90
    +6.50 (+0.27%)
     

  • Crude Oil

    82.31
    -0.38 (-0.46%)
     

  • 10-Yr Bond

    4.5850
    0.0000 (0.00%)
     

  • Nikkei

    38,079.70
    +117.90 (+0.31%)
     

  • Hang Seng

    16,385.87
    +134.03 (+0.82%)
     

  • FTSE Bursa Malaysia

    1,546.06
    +5.64 (+0.37%)
     

  • Jakarta Composite Index

    7,171.35
    +40.51 (+0.57%)
     

  • PSE Index

    6,523.19
    +73.15 (+1.13%)
     

Why Aurora Cannabis Stock Spiked Today

Alexander Carchidi, The Motley Fool
·2-min read

Aurora Cannabis' (NASDAQ: ACB) stock had ratcheted upward by more than 8.1% on Friday at 10:11 a.m. ET after a Cantor Fitzgerald analyst, Pablo Zuanic, adjusted his outlook on the company from neutral to overweight, citing its favorable positioning within the rapidly growing European cannabis market. The upgrade is a welcome reprieve for shareholders, as analysts have overwhelmingly rated Aurora as a hold rather than a buy this year, with a few recommending to sell. The analyst's new outlook is surprising, considering that over the last year, Aurora's quarterly revenue has fallen by more than 10.8%, its total quarterly expenses have risen by above 13.1%, and its quarterly revenue as a proportion of expenses has risen sharply.

Continue reading